Page last updated: 2024-08-17

9,10-dimethyl-1,2-benzanthracene and Severe Combined Immunodeficiency

9,10-dimethyl-1,2-benzanthracene has been researched along with Severe Combined Immunodeficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atillasoy, ES; Elder, DE; Elenitsas, R; Herlyn, M; Montone, KT; Nesbit, M; Sauter, E; Seykora, JT; Soballe, PW1

Other Studies

1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Severe Combined Immunodeficiency

ArticleYear
UVB induces atypical melanocytic lesions and melanoma in human skin.
    The American journal of pathology, 1998, Volume: 152, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Division; DNA, Neoplasm; Humans; Hyperplasia; In Situ Hybridization; Infant, Newborn; Male; Melanocytes; Melanoma; Mice; Mice, Knockout; Mice, SCID; Neoplasms, Radiation-Induced; Severe Combined Immunodeficiency; Skin; Skin Neoplasms; Skin Transplantation; Transplantation, Heterologous; Ultraviolet Rays

1998